ALLEVIATION OF PARKINSONISM BY ANTAGONISM OF EXCITATORY AMINO-ACID TRANSMISSION IN THE MEDIAL SEGMENT OF THE GLOBUS-PALLIDUS IN RAT AND PRIMATE

被引：209

作者：

BROTCHIE, JM ^{[1
]}

MITCHELL, IJ ^{[1
]}

SAMBROOK, MA ^{[1
]}

CROSSMAN, AR ^{[1
]}

机构：

[1] UNIV MANCHESTER,DEPT CELL & STRUCT BIOL,EXPTL NEUROL GRP,MANCHESTER M13 9PT,LANCS,ENGLAND

来源：

MOVEMENT DISORDERS | 1991年 / 6卷 / 02期

关键词：

Excitatory amino acid; Globus pallidus; Kynurenic acid; Parkinson's disease; Striatal cell;

D O I：

10.1002/mds.870060208

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Recent experimental data has made possible the description of the pathophysiological circuitry that mediates parkinsonism. This work has shown that dopamine-denervated striatal cells discharge abnormally and that this ultimately causes cells in the medial segment of the globus pallidus to become abnormally overactive. The main driving force behind the overactive cells in the medial pallidal segment appears to be excess activity in the afferent pathway to it from the subthalamic nucleus. This pathway is known to use an excitatory amino acid (EAA) as its transmitter. It was therefore hypothesized that local blockade of EAA transmission in the medial segment of the globus pallidus should reverse parkinsonism. This hypothesis was tested in rat and primate models of parkinsonism by the direct injection of the EAA antagonist, kynurenic acid, into the medial segment of the globus pallidus. The results demonstrate that this procedure can reverse parkinsonism in a dose-dependent manner, and suggest that manipulation of EAA transmission in the medial segment of the globus pallidus may have therapeutic potential for treating parkinsonism.

引用

页码：133 / 138

页数：6

共 12 条

[1] Mitchell IJ, Clarke CE, Boyce S, Robertson RG, Peggs D, Sambrook MA, Crossman AR., Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2‐deoxyglucose in monkeys exposed to 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine (MPTP), Neuroscience, 32, pp. 213-226, (1989)
[2] Miller WC, Delong MR, Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of parkinsonism, The basal ganglia. II. Structure and function‐Current concepts, 32, pp. 395-403, (1987)
[3] Filion M, Tremblay L, Bedard PJ., Abnormal influences of passive limb movement on the activity of globus pallidus neurons in parkinsonian monkeys, Brain Res, 444, pp. 165-176, (1988)
[4] Augood SJ, Emson PC, Mitchell IJ, Boyce S, Clarke CE, Crossman AR., Cellular localisation of enkephalin gene expression in MPTP treated cynomolgus monkeys, Mol Brain Res, 6, pp. 85-92, (1989)
[5] Smith Y, Parent A., Neurons of the subthalamic nucleus in primates display glutamate but not GABA immunoreactivity, Brain Res, 453, pp. 353-356, (1988)
[6] Brotchie JM, Crossman AR., Evidence for excitatory amino acid mediated subthalamic nucleus efferents in the rat, Br J Pharmacol, 928 P, (1989)
[7] Klockgether T, Turski L, Excitatory amino acids and the basal ganglia: implications for therapy of Parkinson's disease, Trends Neurosci, 12, (1989)
[8] Carlsson M, Carlsson A., The NMDA antagonist MK‐801 causes marked locomotor stimulation in monoaminedepleted mice, J Neural Transm, 75, pp. 221-226, (1989)
[9] Bergman H, Wichmann T, Delong MR., Amelioration of parkinsonian symptoms by inactivation of the subthalamic nucleus in MPTP‐treated monkeys, Mov Disord, 5, (1990)
[10] Robertson RG, Farmery SM, Sambrook MA, Crossman AR., Dyskinesia in the primate following injection of an excitatory amino acid antagonist into the medial segment of the globus pallidus, Brain Res, 476, pp. 317-322, (1989)

← 1 2 →